References
- Stenhammar L, Ansved P, Jansson G, Jansson U. The incidence of childhood celiac disease in Sweden. J Pediatr Gastroenterol Nutr 1987; 6: 707–709
- McNeish A S, Harms H K, Rey J, Shmerling D H, Visakorpi J K, Walker-Smith J A. The diagnosis of celiac disease. Arch Dis Child 1979; 54: 783–786
- Stenhammar L, Kilander A F, Nilsson L Å, Strömberg L, Tarkowski A. Serum gliadin antibodies for detection and control of childhood celiac disease. Acta Paediatr Scand 1984; 73: 657–463
- Scott H, Ek J, Brandtzaeg P. Changes of serum antibody activities to various dietary antigens related to gluten withdrawal or challenge in children with coeliac disease. Int Arch Allergy Appl Immunol 1985; 76: 138–144
- Kilander A F, Nilsson L Å, Gillberg R. Serum antibodies to gliadin in coeliac disease after gluten withdrawal. Scand J Gastroenterol 1987; 22: 29–34
- Menzies I S, Pounder R, Heyer S, Laker M F, Bull J, Wheeler P G, Creamer B. Abnormal intestinal permeability to sugars in villous atrophy. Lancet 1979; 2: 1107–1109
- Hamilton I, Hill A, Bose B, Bouchier I AD, Forsyth J S. Small intestinal permeability in pediatric clinical practice. J Pediatr Gastroenterol Nutr 1987; 6: 697–701
- Bjarnason I, Peters T J, Veall N. A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test. Lancet 1983; 1: 323–325
- Turck D, Ythier H, Maquet E, Deveaux M, Marchandise X, Farriaux J P, Fontaine G. Intestinal permeability to 51CrEDTA in children with Crohn's disease and celiac disease. J Pediatr Gastroenterol Nutr 1987; 6: 535–537
- Chadwick V S, Phillips S F, Hofmann A F. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). Gastroenterology 1977; 73: 241–251
- Jenkins R T, Goodacre R L, Rooney P J, Bienenstock J, Sivakumaran T, Walker W HC. Studies of intestinal permeability in inflammatory diseases using polyethylene glycol 400. Clin Biochem 1986; 19: 298–302
- Lifschitz C H, Irving C S, Marks L M, Klein P D, Finegold M J, Nichols B L. Polyethylene glycol polymers of low molecular weight as probes of intestinal permeability. II. Application to infants and children with intestinal disease. J Lab Clin Med 1986; 108: 37–43
- Philipsen E K, Batsberg W, Christensen A B. Gastrointestinal permeability to polyethylene glycol: an evaluation of urinary recovery of an oral load of polyethylene glycol as a parameter of intestinal permeability in man. Eur J Clin Invest 1988; 18: 139–145
- Greco L, Troncone R, De Vizia B, Poggi V, Mayer M, Grimaldi M. Discriminant analysis for the diagnosis of childhood celiac disease. J Paediatr Gastroenterol Nutr 1987; 6: 538–542
- Fälth-Magnusson K, Kjellman N IM, Magnusson K E, Sundqvist T. Intestinal permeability in healthy and allergic subjects before and after sodium-cromoglycate treatment assessed with different-sized polyethylene glycols (PEG 400 and PEG 1000). Clin Allergy 1984; 14: 277–286
- Fälth-Magnusson K, Kjellman N IM, Odelram H, Sundqvist T, Magnusson K E. Gastrointestinal permeability in children with cow's milk allergy; effect of milk challenge and sodium cromoglycate as assessed with polyethylene glycols (PEG 400 and PEG 1000). Clin Allergy 1986; 16: 543–551
- Alexander J OD. Dermatitis herpetiformis. Major problems in dermatology, A Rook. Saunders Co. Ltd, London 1975; 236–280